Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ProfoundBio Announces Completion of $70 Million Series A+ Financing to Advance Antibody-Drug Conjugate (ADC) Programs into the Clinic 2022-06-02 20:00
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy 2022-06-02 20:00
Winner Medical Acquires Majority Stake in Pingan Medical to Fuel Growth 2022-06-02 11:08
Concord Medical Announces Its Subsidiary's Application Filing for Potential Listing on The Stock Exchange of Hong Kong Limited 2022-06-02 04:15
First AI to Refine Medical Coding by Exploring Therapeutic Data 2022-06-02 01:22
Harbour BioMed Reports the Latest Progress of Next-Generation Fully Human Heavy-chain Antibody HBM4003 with Unique Treg Depletion Mechanism 2022-06-01 21:24
Standigm Signs MOU with Merck Korea for AI drug Discovery Research 2022-06-01 21:00
Burning Rock Receives CE Mark for its OverC™ Multi-Cancer Detection Blood Test Kit 2022-06-01 19:49
Avulux and CR Surfacing partner to make innovative migraine & light sensitivity lenses available through eye-care practitioners across Australia 2022-06-01 05:00
Toku Eyes, Developer of an AI Platform That Accurately Identifies Risk of Heart Attack Using an Eye Image, Expands to The US 2022-06-01 00:00
QureBio Ltd. to Showcase its Q-1802 Clinical Advances at 2022 ASCO Annual Meetings 2022-05-31 22:30
I-Mab Announces Completion of Patient Enrollment in Phase III Clinical Trial of Eftansomatropin alfa for Treatment of Pediatric Growth Hormone Deficiency 2022-05-31 20:00
Volition Achieves CE Mark for Nu.Q® NETs Test 2022-05-31 20:00
GBM AGILE OPENS TO PAXALISIB IN EUROPE 2022-05-31 19:20
Illuccix® Granted Transitional Pass-Through Payment Status 2022-05-31 19:00
Latest Results from AENEAS Study of Hansoh Pharma's Ameile® Published in Top International Academic Journal JCO 2022-05-31 17:56
AffaMed Therapeutics Announces First Patient Dosed in the US Phase 1 Clinical Trial of AM712 in Retinal Disease 2022-05-31 11:30
Nature Cancer Publishes the Collaborative Study Results by Transcenta and Shanghai Jiao Tong University Scientists 2022-05-31 08:08
The Global Fight Against Monkeypox: Zelixir Biotech Predicts Monkeypox Protein Structures 2022-05-30 18:36
InxMed IN10018 at ASCO 2022 demonstrates robust efficacy in patients with platinum-resistant recurrent ovarian cancer 2022-05-30 08:10
1 126 127 128 129 130 432